Business Wire Health News

Research and Markets: The 2010 Report on Anti-Obesity Drugs: World Market Segmentation by City

Sat, 7 Nov 2009 02:00:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c02179/the_2010_report_on) has announced the addition of the "The 2010 Report on Anti-Obesity Drugs: World Market Segmentation by City" report to their offering. This study covers the world outlook for anti-obesity drugs across more than 2000 cities. For the year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the city in question (in millions of U.S. dollar

Halozyme Study Results Demonstrate Significantly Less Absorption Variability for Insulin Lispro Administered with PH20 Enzyme

Sat, 7 Nov 2009 02:00:00 UT

SAN DIEGO--(BUSINESS WIRE)--Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone. When compared to lispro alone, the combination of lispro with PH20 reduced the variability for early and late insulin absorption, the time to maximum concentration (Tmax), and the a

Covidien conclui aquisição da Aspect Medical Systems Inc.

Sat, 7 Nov 2009 01:42:00 UT

DUBLIN--(BUSINESS WIRE)--A Covidien (NYSE: COV), fornecedora líder mundial em produtos de assistência médica, anunciou hoje que concluiu a aquisição anteriormente anunciada da Aspect Medical Systems Inc. por um pagamento agregado de aproximadamente US$ 210 milhões, líquido e de investimentos adquiridos a curto prazo. A oferta de compra expirou à meia-noite, no final do dia 5 de novembro de 2009. Naquela hora, o depositário da oferta informou a Covidie

Riassunto: Covidien porta a termine l'acquisizione di Aspect Medical Systems Inc.

Sat, 7 Nov 2009 01:38:00 UT

DUBLINO--(BUSINESS WIRE)--Covidien (NYSE: COV), leader mondiale nel settore dei prodotti sanitari, ha annunciato oggi di aver completato l'acquisizione precedentemente annunciata Aspect Medical Systems Inc., per un importo complessivo di circa $ 210 milioni al netto delle disponibilità liquide e degli investimenti a breve termine acquisiti. L'offerta di acquisto è scaduta a mezzanotte (ora della costa orientale degli Stati Uniti) del 5 novembre 2009. Il depositario dell'offerta di acqu

Covidien finaliza la adquisición de Aspect Medical Systems Inc.

Sat, 7 Nov 2009 01:38:00 UT

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), proveedor líder mundial de productos para el cuidado de la salud, anunció hoy que ha finalizado la adquisición de Aspect Medical Systems Inc. anteriormente anunciada por la suma total de aproximadamente US$210 millones, neto de caja e inversiones a corto plazo adquiridas. La oferta pública finalizó a las 12:00 de la noche, hora del este, al final del día 5 de noviembre de 2009. En ese momento, el depositario de la ofert

GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010

Sat, 7 Nov 2009 01:15:00 UT

LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif.--(BUSINESS WIRE)--GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S. Food and Drug Administration (FDA) has extended the original Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application (NDA) for GSK1838262/XP13512 (gabapentin enacarbil) to February 9, 2010. The original PDUFA date for this NDA review was November 9, 2009. The FDA determined that a Risk Evaluat

Rite Aid to Present at Credit Suisse Healthcare Conference November 12

Fri, 6 Nov 2009 22:44:00 UT

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE:RAD) announced today that Mary Sammons, chairman and chief executive officer, and Frank Vitrano, chief financial and chief administrative officer, will address the Credit Suisse Healthcare Conference on November 12, 2009. Rite Aid’s presentation is scheduled for approximately 4:00 p.m. MST (6 p.m. EST). Slides from the presentation will be available on Rite Aid's website at www.riteaid.com for all interested parties

$10 Million in Federal Funding for TECO

Fri, 6 Nov 2009 22:40:00 UT

HOUSTON--(BUSINESS WIRE)--Thermal Energy Corp. (TECO) in Houston announced today that it will receive $10 million in federal stimulus funding for its new combined heat and power project at the Texas Medical Center, where TECO provides district heating and cooling service to 18 institutions. Now under construction, the new 45 MW combined heat and power (CHP) plant will increase heating and cooling system efficiencies and help reduce greenhouse gases. TECO projects its CHP system will decrease loc

CardioNet, Inc. Reports Third Quarter 2009 Financial Results

Fri, 6 Nov 2009 22:14:00 UT

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter and nine months ended September 30, 2009. Highlights and Recent Developments Increased patient volume in the third quarter by 46.8% over the third quarter of 2008 Monitored over 260,000 patients nationally since the Company’s inception Increased revenue to $

CPSC to Vote on Intertek Recommendations for Sensible Testing Practices

Fri, 6 Nov 2009 22:07:00 UT

CHICAGO--(BUSINESS WIRE)--The U.S. Consumer Product Safety Commission (CPSC) released a Guidance Document last night to be voted on by the Commission that would adopt recommendations made by Intertek and the American Apparel and Footwear Association (AAFA) in their petition to the agency last July. (See full text of the petition here.) The CPSC’s approval of the Guidance Document on Consumer Product Safety Improvement Act (CPSIA) testing and certification procedures would codify Intertek a

Skilled Healthcare Group to Present at the Credit Suisse 18th Annual Global Health Care Conference

Fri, 6 Nov 2009 21:48:00 UT

FOOTHILL RANCH, Calif.--(BUSINESS WIRE)--Skilled Healthcare Group, Inc. (NYSE: SKH) today announced that Boyd Hendrickson, Chairman and Chief Executive Officer, and Dev Ghose, Executive Vice President and Chief Financial Officer, are scheduled to present at the Credit Suisse 18th Annual Global Health Care Conference on Thursday, November 12, 2009 at 1:00 PM Pacific / 4:00 PM Eastern. The conference is being held at The Arizona Biltmore in Phoenix, AZ. A copy of the presentation will be available

Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of IMS Health, Inc.

Fri, 6 Nov 2009 21:30:00 UT

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of IMS Health, Inc. (“IMS” or the “Company”) (NYSE:RX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to TPG Capital (“TPG”) and the CPP Investment Board (“CPPIB”). The investigation concerns the price to be paid by TPG and CP

Owens & Minor to Participate in Three Upcoming Investor Events

Fri, 6 Nov 2009 21:30:00 UT

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor (NYSE: OMI) today updated its Investor Relations calendar with three upcoming events. Owens & Minor will participate in the 18th Annual Credit Suisse Healthcare Conference in Phoenix, AZ, on Thursday, November 12, 2009, at 11:30 a.m. MST (1:30 p.m. ET). Owens & Minor will present to investors at the 6th Annual Citi Small and Mid-Cap Conference in New York on Thursday, November 19, 2009, at 10:40 a.m. ET. On Thursday, December 10, 2009, Ow

Celgene Corporation to Present at Two Upcoming Investor Conferences

Fri, 6 Nov 2009 21:30:00 UT

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com. Celgene management will provide an overview of the company. On Tuesday, November 10, 2009, Celgene will present at the Merriman Curhan Ford 6th Annual Investor Summit at 10:30 a.m. ET. On Wednesday, November 11, 2009, Celgene will pre

Covidien Completes Acquisition of Aspect Medical Systems Inc.

Fri, 6 Nov 2009 21:18:00 UT

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Aspect Medical Systems Inc. for an aggregate consideration of approximately $210 million, net of cash and short-term investments acquired. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009. At that time, the depositary for the offer advised Covidien that 16,195,245 shares of Aspect common stock h

Florida’s Agency for Health Care Administration Previews Online Personal Health Records for Medicaid Recipients

Fri, 6 Nov 2009 21:18:00 UT

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Florida’s Agency for Health Care Administration (Agency) has previewed the first phase of Florida’s free, Internet-based personal health record, My Florida Health eBook and My Florida eBaby Book. Florida is the first state to offer free personal health records for Medicaid recipients, which was made possible through an innovative partnership between the Agency, Availity, LLC, HealthTrio LLC and Healthwise at no cost to taxpayers. “Thanks to t

Ferro Announces Closing of Common Stock Offering

Fri, 6 Nov 2009 21:15:00 UT

CLEVELAND--(BUSINESS WIRE)--Ferro Corporation (NYSE: FOE) announced today that it has closed on its previously announced common stock offering. The total number of shares sold was 41,112,500, including 5,362,500 shares issued in connection with the exercise of the underwriters’ over-allotment option to purchase additional shares. Ferro intends to use up to $50 million of the net proceeds from the offering to pay the costs associated with its restructuring programs and strategic initiatives

Urgent Care Awareness Week November 9-13

Fri, 6 Nov 2009 21:03:00 UT

WARRENVILLE, Ill.--(BUSINESS WIRE)--Urgent Care Centers around the country will be celebrating the second annual Urgent Care Awareness Week November 9-13th. The goal of Urgent Care Awareness Week is to help educate communities – individuals, families, groups, primary care physicians and emergency departments - about urgent care and how urgent care centers can help serve their healthcare needs, especially during the flu season. Urgent Care Centers provide walk-in, extended-hour medical care

PPD to Present at CHINATRIALS 2009

Fri, 6 Nov 2009 21:00:00 UT

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq:PPDI) today announced Simon Britton, vice president of clinical development, Asia Pacific, will present at the CHINATRIALS 2009 Global Clinical Development Summit in Beijing on November 8-10. His panel presentation will provide insight to clinical development professionals on creating the best clinical strategy for China and East Asia. PPD is the platinum sponsor of this year’s event. Britton will join a panel of experts in discussing ne

PharMerica to Present at the Credit Suisse 18th Annual Healthcare Conference

Fri, 6 Nov 2009 20:39:00 UT

LOUISVILLE, Ky.--(BUSINESS WIRE)--PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy and hospital pharmacy management services, today announced that Gregory S. Weisher, Chief Executive Officer, will make a presentation regarding the Company at the Credit Suisse 18th Annual Healthcare Conference in Phoenix, Arizona, on Wednesday, November 11, 2009, at 10:00 a.m. Mountain Time. The Company also announced that a live broadcast of its conference presentation, as well a

Washington, D.C.: AHF Opens ‘Men’s Wellness Center’ at ‘Blair Underwood’ Healthcare Center

Fri, 6 Nov 2009 20:27:00 UT

WASHINGTON--(BUSINESS WIRE)--On Thursday, November 5th, AIDS Healthcare Foundation (AHF), the largest global AIDS organization, which provides medical care and/or services to more than 120,000 individuals in 22 countries worldwide, opened a Men's Wellness Center at the new ‘AHF Blair Underwood Healthcare Center’ located in Washington D.C. The new center will provide, at no cost to clients, confidential and comprehensive sexual health services for men—including HIV and STD (sexu

2009 Mid-Atlantic Bio Conference Attracts Record Number of Bioscience Companies

Fri, 6 Nov 2009 20:24:00 UT

WASHINGTON--(BUSINESS WIRE)--The 2009 Mid-Atlantic Bio Conference drew more than 750 participants—including a record number of more than 300 bioscience companies in attendance—for its annual bioscience and investor conference. For its fifth year, the conference brought together industry luminaries, innovators, capital sources, academic and research organizations, and government agencies representing 30 states and the international community. During today’s Closing Plenary Lunch

AIPL Announces Premier Opthalmic Pathology Consultation Group

Fri, 6 Nov 2009 20:04:00 UT

SILVER SPRING, Md.--(BUSINESS WIRE)--American International Pathology Laboratories™ (AIPL™) announces the formation of the first ever multi-subspecialty group to diagnose Opthalmic Pathology cases. With the small number of Opthalmic Pathologists in the United States, the need exists for a comprehensive group to render expert diagnostic opinions on cases involving the eye. The team will focus on all types of Opthalmic Pathology cases, including temporal arteritis, melanoma, epithelial

Quality Systems, Inc. to Present at Credit Suisse 18th Annual Healthcare Conference

Fri, 6 Nov 2009 20:01:00 UT

IRVINE, Calif.--(BUSINESS WIRE)--Quality Systems, Inc. (NASDAQ: QSII) announced today that its management plans to present its corporate story at the upcoming 2009 Credit Suisse Healthcare Conference. The conference, which will showcase more than 100 public companies within the healthcare sector for institutional investors, is scheduled for Wednesday, November 11, 2009 - Friday, November 13, 2009, at the Arizona Biltmore Resort & Spa in Phoenix. Quality Systems’ Chief Financial Officer

Aspyra to Demonstrate Latest Release of AccessNET PACS with Mammography Viewing (510(k) Pending) at RSNA 2009

Fri, 6 Nov 2009 19:49:00 UT

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessNET, the Company’s PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A. The latest release of Aspyra’s AccessNET PACS (Picture Archive Communication System), version 6.5.0 includes the IHE compliant hanging protocols and display capabilitie

Celsion to Hold Third Quarter 2009 Financial Results Conference Call Tuesday, November 10, 2009

Fri, 6 Nov 2009 19:45:00 UT

COLUMBIA, Md.--(BUSINESS WIRE)--Celsion Corporation (NASDAQ:CLSN), a late stage clinical oncology development company that is leveraging its heat activated liposomal technology platform to encapsulate and deliver high concentrations of proven chemotherapeutics, today announced that it will hold a conference call to discuss third quarter 2009 results at 11:00 a.m. Eastern Time on Tuesday, November 10, 2009. To participate in the call, interested parties may dial 1-877-852-6580 or 1-719-325-4751 (

Patterson Companies Second Quarter Conference Call Scheduled for November 19, 2009

Fri, 6 Nov 2009 19:24:00 UT

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its conference call to review operating results for the second quarter of fiscal 2010 on Thursday, November 19 at 10:00 AM Eastern. The Patterson earnings release will be issued before the market opens that day. Investors can access a live webcast of the conference call by visiting the investor relations section of the Patterson Companies website, www.PattersonCompanies.com/Webcasts. The webcas

CCAGW Urges Rep. Hill to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 19:16:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Baron Hill (D-Ind.) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible collection of ill-a

CCAGW Urges Rep. Ellsworth to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 18:48:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Brad Ellsworth (D-Ind.) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible collection of i

CCAGW Urges Rep. Gordon to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 18:47:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Bart Gordon (D-Tenn.) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible collection of ill

Brigadier General Rebecca S. Halstead Shares Mission to Continue Serving on Veterans Day

Fri, 6 Nov 2009 18:45:00 UT

DALLAS--(BUSINESS WIRE)--Parker College of Chiropractic will host a Veterans Day celebration in honor of United States veterans and active military members. Guest speaker Brigadier General Rebecca S. Halstead will share her journey as the first woman to serve as Chief of Ordnance for the United States Army. In addition she will speak about the importance of veterans’ mission to continue serving after duty. Local military officers and community members are invited to attend the celebration

CCAGW Urges Rep. Donnelly to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 18:43:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Joe Donnelly (D-Ind.) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible collection of ill

CCAGW Urges Rep. Herseth Sandlin to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 18:42:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Stephanie Herseth Sandlin (D-S.D.) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible coll

CCAGW Urges Rep. Davis to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 18:39:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Lincoln Davis (D-Tenn.) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible collection of i

CCAGW Urges Rep. Giffords to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 18:38:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Gabrielle Giffords (D-Ariz.) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible collection

CCAGW Urges Rep. Minnick to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 18:31:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Walt Minnick (D-Idaho) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible collection of il

CCAGW Urges Rep. Chandler to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 18:29:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Ben Chandler (D-Ky.) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible collection of ill-

CCAGW Urges Rep. Childers to Oppose the Pelosi Healthcare Bill

Fri, 6 Nov 2009 18:29:00 UT

WASHINGTON--(BUSINESS WIRE)--The Council for Citizens Against Government Waste (CCAGW), the nation’s premier taxpayer watchdog lobbying group, today urges Rep. Travis Childers (D-Miss.) to vote “nay” on H.R. 3962, the 1990-page, $1 trillion Pelosi healthcare reform bill, which is scheduled for a vote on Saturday. “America cannot afford the price tag for this monstrosity,” said CCAGW President Tom Schatz. “It may be the most fiscally irresponsible collection of

The Lowe Law Firm Files Suit over Alleged Botox Overdose

Fri, 6 Nov 2009 18:27:00 UT

ST. LOUIS--(BUSINESS WIRE)--St. Louis-based The Lowe Law Firm has filed a lawsuit on behalf of a man who experienced partial respiratory paralysis and other side effects after receiving an overdose of the Botox being used to treat his muscle spasticity. The suit, Richard A. Hart v. Yi Pan, Tenet HealthSystem SL Inc., d/b/a St. Louis University Hospital and Allergan USA Inc., cause no. 0922-CC09485, was filed in St. Louis Circuit Court on Oct. 21. The plaintiff, Richard Hart, suffers from a medic

Research and Markets: Lebanon Pharmaceuticals and Healthcare Report Q4 2009

Fri, 6 Nov 2009 18:14:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/48b0c6/lebanon_pharmaceut) has announced the addition of the "Lebanon Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. Lebanon Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Lebanon's pharmaceu

Prestige Ameritech Reopening Former Kimberly-Clark Surgical Mask Factory to Fight H1N1, Create US Jobs

Fri, 6 Nov 2009 18:02:00 UT

NORTH RICHLAND HILLS, Texas--(BUSINESS WIRE)--Prestige Ameritech is turning a vacant, former Kimberly-Clark surgical mask factory into a Global Pandemic Preparedness and Response Center. The 220,000 square foot facility, on 17 acres in North Richland Hills, Texas, will open by January 31, 2010. Besides supplying America’s hospitals with their normal supplies of masks and respirators, the center will help the US and other countries build surgical mask and N95 respirator stockpiles for use d

24 Hour Fitness Celebrates Grand Opening of Its Largest Club on Oahu

Fri, 6 Nov 2009 18:00:00 UT

SAN RAMON, Calif.--(BUSINESS WIRE)--24 Hour Fitness, the largest privately owned U.S. fitness chain and leading health club pioneer, today announced the grand opening of the 24 Hour Fitness Pearl City Super Sport. The new club offers state-of-the-art amenities, including innovative group exercise classes, an indoor pool, steam room, a full-sized basketball court and more. Free seven day passes to the club are available at www.24hourfitness.com. The Honolulu team invites the public to come experi

Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council

Fri, 6 Nov 2009 18:00:00 UT

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the Mass Technology Leadership Council, Inc. named Phase Forward Private Sector Company of the Year at the 2009 Mass Technology Leadership Awards in Boston last night. Honoring Massachusetts companies and individuals who best exemplify leadership and excellence in business and technology, the Technology Leadership Awards recognize out

UHS Third Quarter 2009 Earnings Call

Fri, 6 Nov 2009 17:54:00 UT

EDINA, Minn.--(BUSINESS WIRE)--Universal Hospital Services, Inc., a leading nationwide provider of medical equipment outsourcing and lifecycle solutions, will hold its quarterly conference call to discuss 2009 third quarter results on Tuesday, November 10, 2009, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). To participate, call (877) 586-2667 and advise the operator you would like to participate in the UHS Third Quarter 2009 Call with Gary Blackford. A taped replay of this call will be av

Mead Johnson Webcasts Investor Meeting

Fri, 6 Nov 2009 17:51:00 UT

GLENVIEW, Ill.--(BUSINESS WIRE)--Mead Johnson Nutrition Company (NYSE: MJN) will host a conference for analysts and investors on Wednesday, Nov. 11, 2009. Members of the company’s senior management team will make presentations beginning at 9 a.m. CST and concluding at 12:30 p.m. The program will be broadcast live over the Internet. To access the broadcast, go to meadjohnson.com and click on the Investors tab. A replay of the program will be available on the Website after 3:00 CST that same

CEL-SCI's L.E.A.P.S.™ H1N1 Flu Development Seen as Credibility Booster

Fri, 6 Nov 2009 17:34:00 UT

LOS ANGELES--(BUSINESS WIRE)--BioMedReports.com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that one of several expected key news developments has been announced by CEL-SCI Corporation (NYSE Amex: CVM), today. An Institutional Review Board of The Johns Hopkins University School of Medicine (Johns Hopkins) has given clearance for the Company's first clinical study involving th

MEDBIZONICS, LLC Announces Recent Acquisitions

Fri, 6 Nov 2009 17:32:00 UT

RICHMOND, Va.--(BUSINESS WIRE)--MEDBIZONICS, LLC has acquired Healthcare Business Consultants, LLC (HBC) & Docs Billing Solutions, LLC (DBS). The acquisitions will expand MEDBIZONICS services into provider practice management advisory and revenue cycle management. HBC brings over 30 years experience of providing practice, financial, and business advisory services to healthcare providers throughout the Mid-Atlantic region. See www.consulthbc.com. DBS, through its channel partner relationship

Research and Markets: Latest Report for the United States Pharmaceuticals and Healthcare Industry as We Find out Healthcare Spending in 2008 Reached US$2.3 Trillion

Fri, 6 Nov 2009 17:30:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/00af33/united_states_phar) has announced the addition of the "United States Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. United States Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on the Uni

Novak Druce + Quigg LLP Speaks on Patent Reform at BioFlorida Annual Conference

Fri, 6 Nov 2009 17:26:00 UT

ORLANDO, Fla.--(BUSINESS WIRE)--This morning, Novak Druce + Quigg LLP Executive Partner Tracy W. Druce spoke on patent reform during the “Federal Policies Impacting Biosciences” session at BioFlorida’s 12th Annual Conference, “Convergence, Creating Biosynergy” in Orlando. Mr. Druce’s presentation, “Changes in the Patent Reform Act of 2009,” discussed potential changes to the life sciences industry that could result from the passage of the Patent Re

Samenvatting: Covidien voltooit tenderaanbod voor aandelen van Aspect Medical Systems, Inc.

Fri, 6 Nov 2009 17:21:00 UT

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), leverancier van producten voor de gezondheidszorg, meldt de geslaagde voltooiing van zijn tenderaanbod via dochteronderneming Transformer Delaware Corp., voor de aankoop van alle uitstaande gewone aandelen van Aspect Medical Systems, Inc. Het aanbod verviel om middernacht ET van 5 november 2009, en werd niet verlengd. De depositaris voor het aanbod heeft Covidien geadviseerd dat vanaf de vervaldatum van het aanbod een totaal van ongeveer 16.195.245

FDA Lags on 510(k) Medical Device Approvals

Fri, 6 Nov 2009 17:18:00 UT

BOSTON--(BUSINESS WIRE)--According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — e

Research and Markets: Brazil's Generic Medicines Continue to grow at a Higher Rate than Overall Pharmacy Sales, And Are Expected to Represent 20% Of the Sector by Volume In 2010

Fri, 6 Nov 2009 17:00:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/b3f479/the_pharmaceutical) has announced the addition of the "The Pharmaceutical Market: Brazil" report to their offering. Due to the depreciation of Brazil's currency against the US dollar, the Brazilian pharmaceutical market has fallen in dollar values in 2009. Controlled drug prices are increasing below inflational levels and demand is contained by a falling economic growth projected in 2009. For the indu

JohnsonDiversey annonce que la société s’engage à tripler la réduction absolue de ses émissions de gaz à effet de serre d’ici 2013 dans le cadre du programme Climate Savers du WWF

Fri, 6 Nov 2009 16:36:00 UT

STURTEVANT, Wisconsin--(BUSINESS WIRE)--JohnsonDiversey a annoncé aujourd’hui s’être engagée à tripler la réduction de ses émissions de gaz à effet de serre (GES) dans le cadre du programme Climate Savers du Fonds mondial pour la nature (World Wildlife Fund, WWF). La promesse initiale à la pointe du secteur, faite par la société en 2008 lorsqu’elle a rejoint le programme Climate Savers, de réduire de 8 % ses émiss

Research and Markets: In 2008, Argentina's Pharma Annual Sales Rose By 26.8% In Local Terms, Reaching 9.6 Billion Pesos (US$3.1 Billion)

Fri, 6 Nov 2009 16:25:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a8887a/the_pharmaceutical) has announced the addition of the "The Pharmaceutical Market: Argentina" report to their offering. In terms of size, the Argentine market is much smaller than Mexico and Brazil, but similar to Venezuela. The pharmacy sector, traditionally dominated by branded products, has showed an impressive double-digit growth in recent years but the growth rate is expected to slow down in the

Washington Biotechnology & Biomedical Association’s New “Healthcare Economics in WA” Breaking News is Powered by MedIntelliBase® Intelligence Services

Fri, 6 Nov 2009 16:10:00 UT

REDMOND, Wash.--(BUSINESS WIRE)--Visitors to the newly branded and redesigned website of the Washington Biotechnology & Biomedical Association (WBBA) to be featured at the WBBA’s Annual Meeting today will get free, timely, Washington state-focused biotech and medtech news through its “Economic Issues in WA Healthcare” Breaking News feature. This new feature, powered by MedIntelliBase® Intelligence Services, provides a precisely focused RSS feed of economic, government

Academy Award-Winning Actor Forest Whitaker to Keynote Symposium on Maternal and Infant Mortality in Africa

Fri, 6 Nov 2009 16:00:00 UT

PASADENA, Calif.--(BUSINESS WIRE)--Producer, director and Oscar-winning actor, Forest Whitaker, will provide the keynote address at a symposium on maternal and infant mortality tomorrow at the California Institute of Technology from 11 a.m. to 2 p.m. The symposium, entitled “Women and Children First” will explore why so many mothers and young children die in Africa and will highlight innovative efforts to fight the world’s most urgent and tragic crisis. A woman in sub-Saharan A

Health Care Leaders to Discuss Recent Interoperability Successes

Fri, 6 Nov 2009 15:34:00 UT

JACKSONVILLE, Fla.--(BUSINESS WIRE)--A panel of executives representing public-sector health, health care providers, health care information technology, and health plans will address the value of collaboration and the challenges inherent to interoperability, especially as both topics pertain to health information networks. With so much happening in health information technology today – especially at the federal level – this executive panel is uniquely qualified to discuss timely, in-

DocSite PQRI Program a Success for 2008 Submitters

Fri, 6 Nov 2009 15:30:00 UT

RALEIGH, N.C.--(BUSINESS WIRE)--DocSite®, a leader in point-of-care decision support, quality performance management and health information exchange services to the healthcare industry, announced today that their Physician’s Quality Reporting Initiative (PQRI) customers are receiving their 2008 PQRI incentive bonuses from the Centers for Medicare and Medicaid Services (CMS). CMS will continue to distribute 2008 incentive payments through the end of November, and approved physicians wi

Research and Markets: Consumption of Anxiolytics, Soporifics, Sedatives and Antidepressants in Portugal Increased By 32% between 2002 And 2008

Fri, 6 Nov 2009 15:11:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/5417ca/portugal_pharmaceu) has announced the addition of the "Portugal Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. Portugal Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Portugal's pharmac

Fresenius Medical Care North America Acquires Health IT Services Group, Acumen nEHR

Fri, 6 Nov 2009 15:09:00 UT

WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care North America, operator of the nation’s leading network of dialysis facilities, today announced it has purchased Nashville-based Health IT Services Group (HITSG) and its portfolio of products including Acumen nEHR, a nephrology-specific electronic health record. A web-enabled application designed by nephrologists for nephrologists, Acumen nEHR provides physician practices with a comprehensive clinical system integrating care within th

Locus Pharmaceuticals Announces Focus on Drug Discovery Collaboration Business, Branded as Ansaris

Fri, 6 Nov 2009 15:06:00 UT

BLUE BELL, Pa.--(BUSINESS WIRE)--Locus Pharmaceuticals, a drug company that has developed its own internal and partnered pipeline, focusing on oncology, immunology, and inflammatory targets, today announced that in conjunction with a transformation to a drug discovery collaboration business model, it has created a new division, Ansaris, which will include most of its operations and personnel. Ansaris was formed to leverage the strengths and fully realize the value of Locus’ drug discovery

MedRisk, LLC to Offer Clients Benefit Informatics Data Analysis and Reporting Solutions

Fri, 6 Nov 2009 15:06:00 UT

TULSA, Okla.--(BUSINESS WIRE)--Managing risk for health plans, HMOs, self-funded employers and capitated medical groups requires comprehensive access to healthcare data to make the most informed decisions. MedRisk, LLC has contracted with Benefit Informatics to assist clients in managing risk by integrating proven data analysis and reporting solutions. MedRisk, LLC provides reinsurance brokerage services to managed care health plans, self-funded employers, physicians and hospitals. By utilizing

HFMA’s New PATIENT FRIENDLY BILLING® Report Offers Strategies for Achieving Revenue Cycle Excellence

Fri, 6 Nov 2009 15:00:00 UT

CHICAGO--(BUSINESS WIRE)--Revenue cycle excellence can be achieved by all hospitals and health systems, regardless of an organization’s financial means or patient mix, according to the Healthcare Financial Management Association’s latest PATIENT FRIENDLY BILLING® Project report, Strategies for a High-Performance Revenue Cycle. The 37-page report was released today at HFMA’s Revenue Cycle Strategies Conference in Chicago. Based on visits to high-performing sites across the

Research and Markets: Peru Pharmaceuticals and Healthcare Report Q4 2009 - Independent Forecasts and Competitive Intelligence on Peru's Pharmaceuticals and Healthcare Industry

Fri, 6 Nov 2009 15:00:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c80cfb/peru_pharmaceutica) has announced the addition of the "Peru Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. Peru Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Peru's pharmaceuticals an

Medtronic Receives President’s “E” Award in Recognition of Its Support of U.S. Exports

Fri, 6 Nov 2009 15:00:00 UT

MINNEAPOLIS--(BUSINESS WIRE)--Recognizing its significant contributions to increasing U.S. exports, Medtronic, Inc., (NYSE: MDT) received President Barack Obama’s “E” Award on Thursday, Nov. 5. The ceremony, held in the U.S. Department of Commerce, was part of the District Export Council Conference in Washington D.C. The award recognized Medtronic and other individuals and companies for their efforts in promoting and increasing U.S. exports. “We are pleased to receive thi

Research and Markets: The New York General Surgery Board Review - a Comprehensive and Intensive Case-Based Review

Fri, 6 Nov 2009 15:00:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/106ab3/the_new_york_gener) has announced the addition of the "The New York General Surgery Board Review" report to their offering. The New York General Surgery Board Review course is a comprehensive and intensive case-based review that is designed to help candidates complete preparation for the American Board of Surgery Qualifying, Certifying and Recertification Examinations. It also prepares surgical resid

Research and Markets: By 2013, The Value of Lithuania's Prescription and Over-The-Counter (OTC) Markets is to Reach a Value of LTL2.13bn

Fri, 6 Nov 2009 14:46:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/56a15b/lithuania_pharmace) has announced the addition of the "Lithuania Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. Lithuania Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Lithuania's pha

Colgate-Palmolive Co UK Regulatory Announcement: Colgate-Palmolive Webcasts Presentation at the Morgan Stanley Global Consumer & Retail Conference

Fri, 6 Nov 2009 14:35:00 UT

NEW YORK--(BUSINESS WIRE)--Regulatory News: Colgate-Palmolive (NYSE: CL) executives, Fabian Garcia, EVP, President, Colgate-Latin America & Global Sustainability and Franck Moison, President, Global Marketing, Supply Chain & Technology, will present on Thursday, November 19, 2009 at 7:30 a.m. ET at the Morgan Stanley Global Consumer & Retail Conference. Investors may access a live webcast of this presentation on Colgate’s web site at http://www.colgate.com. For those unable to

Colgate-Palmolive Webcasts Presentation at the Morgan Stanley Global Consumer & Retail Conference

Fri, 6 Nov 2009 14:35:00 UT

PPD Completes Acquisition of Excel PharmaStudies

Fri, 6 Nov 2009 14:28:00 UT

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPDI) today announced it has completed its acquisition of Excel PharmaStudies, Inc., the market leader and one of the largest contract research organizations in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions it to capitalize on the tremendous growth of the outsourcing market in Asia Pacific. The acquisition significantly increases PPD’s employee and client base in the

Health Management Associates, Inc. to Present at the 2009 Credit Suisse Healthcare Conference

Fri, 6 Nov 2009 14:24:00 UT

NAPLES, Fla.--(BUSINESS WIRE)--Health Management Associates, Inc. (NYSE:HMA) announced today that its management will present at the 2009 Credit Suisse Healthcare Conference to be held November 11 - 13, 2009, at the Arizona Biltmore Resort and Spa in Phoenix, Arizona. HMA's management will give its presentation on Thursday, November 12, 2009 at 11:00 a.m. MT. The presentation will be webcast live over the Internet via HMA's website (http://www.hma.com). Listeners are encouraged to go to the Inve

JohnsonDiversey anuncia compromisso para triplicar sua redução absoluta de emissões de gás-estufa até 2013, dentro do programa Climate Savers da WWF

Fri, 6 Nov 2009 14:20:00 UT

STURTEVANT, Wisconsin--(BUSINESS WIRE)--A JohnsonDiversey anunciou hoje um compromisso de triplicar sua redução de emissões de gás-estufa, dentro do programa “Climate Savers” da World Wildlife Fund (WWF). O compromisso original, líder da indústria, de redução de 8%, feito pela empresa em 2008, quando ela aderiu ao programa Climate Savers, é agora de 25% e será atingido no período de tempo originalmente comprometido, no final de 2

Helix BioMedix Reports Third Quarter 2009 Financial Results

Fri, 6 Nov 2009 14:05:00 UT

BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced financial results for the third quarter ended September 30, 2009. Third quarter 2009 revenue was approximately $98,000 compared to revenue of approximately $138,000 in the second quarter of 2009 and approximately $157,000 in the third quarter of 2008. Gross margins improved to 46.1% in the third quarter 2009, compared to 37.0% in the same period a year ago, primarily due to an

LabCorp is Scheduled to Present at the Credit Suisse 18th Annual Healthcare Conference

Fri, 6 Nov 2009 14:00:00 UT

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, is scheduled to speak at the Credit Suisse 18th Annual Healthcare Conference in Phoenix AZ. LabCorp’s presentation is planned for Friday, November 13, 2009 at 9:30 a.m. (Mountain Standard Time). A live audio webcast of the presentation will be available via the Company Web site at w

RiskMetrics Group Recommends Stockholders Vote “FOR” Life Sciences Research/Lion Holdings Merger

Fri, 6 Nov 2009 14:00:00 UT

EAST MILLSTONE, N.J.--(BUSINESS WIRE)--Life Sciences Research, Inc. (NYSE Arca: LSR) announced today that RiskMetrics Group (formerly Institutional Shareholder Services), a leading proxy advisory firm, has recommended that LSR stockholders vote “FOR” the approval of the merger of LSR and Lion Merger Corp. pursuant to the Agreement and Plan of Merger, dated as of July 8, 2009, among LSR, Lion Merger Corp. and Lion Holdings, Inc. at the upcoming special meeting of stockholders schedule

Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences

Fri, 6 Nov 2009 13:58:00 UT

BRISTOL, Tenn.--(BUSINESS WIRE)--Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead’s investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death. "Th

Nature’s Sunshine Products Reports Third Quarter Operating Results

Fri, 6 Nov 2009 13:55:00 UT

PROVO, Utah--(BUSINESS WIRE)--Nature’s Sunshine Products, Inc. (NASDAQ:NATR), a leading manufacturer and marketer of encapsulated herbs and vitamins, today reported financial operating results for the three and nine month periods ended September 30, 2009. For the quarter, net sales revenue totaled $85.8 million, compared to $92.7 million for the same three-month period in 2008, a 7.4 percent decline, primarily attributable to the global economic downturn and the adverse effect of foreign c

Genetix Pharmaceuticals Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD)

Fri, 6 Nov 2009 13:30:00 UT

CAMBRIGE, Mass.--(BUSINESS WIRE)--Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced today the company’s clinical program to treat Adrenoleukodystrophy (ALD). The company is developing a gene therapy product in collaboration with Professor Patrick Aubourg and Doctor Nathalie Cartier of the National Institute of Health and Medical Research (INSERM). Genetix is planning to file an IND to expand the development in the US, as well as to expand the ongoing trial

Covidien encerra com sucesso oferta pública de aquisição de ações da Aspect Medical Systems, Inc.

Fri, 6 Nov 2009 13:26:00 UT

DUBLIN--(BUSINESS WIRE)--A Covidien (NYSE: COV), companhia líder global em produtos de assistência à saúde, anunciou hoje o encerramento bem sucedido de sua oferta pública de aquisição de todas as ações em circulação da Aspect Medical Systems, Inc. por intermédio de sua subsidiária Transformer Delaware Corp. A oferta pública de aquisição expirou às 24:00 horas ET (horário dos EUA) do dia 5 de novembro de 20

QuantRx Debuts Flagship Diagnostic Reader Device (Q-Reader™) at MEDICA 2009, the World’s Leading Medical Trade Fair

Fri, 6 Nov 2009 13:22:00 UT

DOYLESTOWN, Pa.--(BUSINESS WIRE)--QuantRx® Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today announced that the Company will demonstrate its latest technology at MEDICA 2009, the world's leading medical trade fair, to be held November 18-21, 2009, in Düsseldorf, Germany. The trade show will be host to a milestone event for QuantRx as the point-of-care (POC) medical device pion

Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at Credit Suisse Conference

Fri, 6 Nov 2009 13:15:00 UT

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that its presentation at the 2009 Annual Credit Suisse Health Care Conference will be webcast and may be accessed at www.sucampo.com. A member of Sucampo Pharmaceuticals’ senior management team will present an overview of the company on Wednesday, November 11, 2009, at 5 pm Mountain Time, or 7 pm Eastern Time. Investors interested in listening to the live webcast should log on before the start time

Burlington, Vermont Named #1 on Self Magazine’s 10th Annual Survey of America’s Healthiest Places for Women

Fri, 6 Nov 2009 13:14:00 UT

NEW YORK--(BUSINESS WIRE)--SELF, the national women’s well-being magazine, announces Burlington, Vermont as the nation’s healthiest city in its 10th annual Healthiest Places for Women survey. Analyzing 100 U.S. metropolitan areas, this examination is the most comprehensive of its kind. Using a broad scope of research criteria, SELF evaluated more than 8,000 bits of data to determine each city’s level of healthy living. SELF polled a panel of experts to find out which factors mo

Omnicare to Present at the Credit Suisse 18th Annual Healthcare Conference

Fri, 6 Nov 2009 13:00:00 UT

COVINGTON, Ky.--(BUSINESS WIRE)--Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, announced today that it will participate in the Credit Suisse 18th Annual Healthcare Conference on November 11 at 1:00 p.m. EST in Phoenix, Arizona. Presenting for Omnicare will be Joel F. Gemunder, president and chief executive officer. The presentation will be broadcast live over the Internet and can be accessed at http://w.on24.com/r.htm?e=174681&s=1&k=AC156CE46FBC1EE

Hooper Holmes Announces Third Quarter 2009 Results

Fri, 6 Nov 2009 13:00:00 UT

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Hooper Holmes (NYSE Amex: HH) today announced financial results for the three and nine months ended September 30, 2009. Consolidated revenues totaled $43.8 million for the third quarter of 2009, representing a 7% revenue decline from the $47.2 million in the third quarter of 2008. This is an improvement for the third quarter of 2009 in comparison to the 10% revenue decline experienced in the first half of 2009. The Company recorded a net loss of $0.7 million

Esker Signs US $200,000 Agreement with Leading Medical Company in Australia

Fri, 6 Nov 2009 13:00:00 UT

MADISON, Wis.--(BUSINESS WIRE)--Esker, the leader in document process automation solutions, announced today that it has signed an agreement totaling approximately USD 200,000 with a leading medical diagnostics and surgical equipment company in Australia to automate processing of sales orders into the company’s SAP system with Esker DeliveryWare. The company also continues to use Esker DeliveryWare for delivery of outbound business documents. Anticipating an increase in the number of incomi

New USB Medical Health Information Card Aims to Save Lives, Time and Money

Fri, 6 Nov 2009 13:00:00 UT

LOUISVILLE, Ky.--(BUSINESS WIRE)--If you’re severely injured in an accident, stricken by an allergic reaction, or impaired by a stroke, heart attack or seizure, how can you possibly relay important medical information to first responders? Have you ever wished you could avoid carrying stacks of health records and lists of prescriptions with you to your doctor’s office, only to have to copy that information by hand onto form after form? With a goal of saving lives and making doctor tri

GTC Biotherapeutics Reports Third Quarter 2009 Financial Results

Fri, 6 Nov 2009 13:00:00 UT

FRAMINGHAM, Mass.--(BUSINESS WIRE)--GTC Biotherapeutics, Inc.’s ("GTC", NASDAQ: GTCB) total net loss for the third quarter ended September 27, 2009 was $5.1 million, or $0.48 per share, compared with $6.1 million, or $0.59 per share, in the third quarter of 2008. The total net loss for the first nine months of 2009 was $26.2 million, or $2.51 per share, compared to $16.5 million, or $1.71 per share, for the first nine months of 2008. “The financing completed earlier this week with LF

JohnsonDiversey anuncia su compromiso de triplicar la reducción absoluta de emisiones de gas de invernadero para 2013 bajo el programa Protectores del clima del Fondo Mundial para la Vida Silvestre (WWF)

Fri, 6 Nov 2009 12:50:00 UT

STURTEVANT, Wisconsin--(BUSINESS WIRE)--JohnsonDiversey anunció hoy su compromiso de triplicar la reducción de emisiones de gas de invernadero (Greenhouse Gas, GHG) bajo el programa Climate Savers (Protectores del clima) de la Fundación para la Vida Silvestre (World Wildlife Fund, WWF). La promesa original de la compañía de reducir un 8 por ciento dichas emisiones, que constituyó el compromiso más destacado de la industria y fue realizado en 2008 cuando se uni&

WellAWARE Systems and It’s Never 2 Late Announce Partnership to Help Seniors Age-in-Place

Fri, 6 Nov 2009 12:30:00 UT

CHICAGO--(BUSINESS WIRE)--WellAWARE Systems: WHAT: WellAWARE Systems and It’s Never 2 Late today announced a strategic partnership to offer the latest technology to help seniors age-in-place. As the leading developer of next-generation wellness monitoring solutions for senior care providers, WellAWARE offers a low-cost monitoring solution that gathers and reports behavioral and wellness information of a cared-for individual, in his/her home or at a senior living facility. It’s Never

TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post

Fri, 6 Nov 2009 12:30:00 UT

LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced today the appointment of Julie Lekstrom Himes, M.D. to join TARIS in the position of Chief Medical Officer and Senior Vice President for Clinical Development. Dr. Himes has broad clinical research and operations experience within the biopharmaceutical industry, including Coley Pharmaceuticals and Millennium Pharmaceuticals. Prio

Medical Action Industries Reports Strong Second Quarter 2010 Fiscal Results

Fri, 6 Nov 2009 12:30:00 UT

BRENTWOOD, N.Y.--(BUSINESS WIRE)--Medical Action Industries Inc. (NASDAQ/MDCI), a leading supplier of medical and surgical disposable products, today reported second quarter 2010 results highlighted by increases in both net income and gross margin versus the prior year period. Net sales for the three months ended September 30, 2009 totaled $75,060,000, an increase of $1,236,000, or 1.7% above the $73,824,000 in net sales reported for the three months ended September 30, 2008. Net income for the

Halozyme Therapeutics Reports Third Quarter 2009 Financial Results

Fri, 6 Nov 2009 12:29:00 UT

SAN DIEGO--(BUSINESS WIRE)--Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009. “Our alliances have continued to achieve strong progress with Roche’s initiation of the Phase 3 registration trial for subcutaneous Herceptin, and Baxte

RXi Pharmaceuticals Appoints Noah D. Beerman as CEO

Fri, 6 Nov 2009 12:15:00 UT

WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Noah D. Beerman has joined the company as its new President and Chief Executive Officer. The appointment of Mr. Beerman as CEO is part of a planned succession in leadership as the company looks to advance from the research stage to product development and exe

ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society

Fri, 6 Nov 2009 12:13:00 UT

NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. As previously announced, having achieved the study-specified efficacy milestone following planned safety and efficacy review by the Data Committee, a panel of internation

Samenvatting: JohnsonDiversey meldt voornemen tot verdrievoudiging van broeikasgasreductie tegen 2013 ihkv het Climate Savers-programma van het WWF

Fri, 6 Nov 2009 12:08:00 UT

STURTEVANT, Wis.--(BUSINESS WIRE)--JohnsonDiversey verbindt zich aan een verdrievoudiging van zijn reductie van broeikasgassen onder het Climate Savers-programma van het World Wildlife Fund (WWF). De originele belofte van 8 procent reductie die JohnsonDiversey deed toen het in 2008 tot het Climate Savers-programma toetrad, is nu bijgesteld naar 25 procent en zal worden gerealiseerd in het oorspronkelijk gestelde tijdskader dat afloopt in 2013. Hiermee is JohnsonDiversey een van de eerste Climate

JohnsonDiversey verpflichtet sich im Rahmen des Klimaschutzprogramms des WWF zur Verdreifachung der absoluten Senkung seiner Treibhausgasemissionen bis 2013

Fri, 6 Nov 2009 12:06:00 UT

STURTEVANT, Wisconsin--(BUSINESS WIRE)--Das Unternehmen JohnsonDiversey hat heute seine Verpflichtung angekündigt, die Reduzierung seiner Treibhausgasemissionen im Rahmen des Klimaschutzprogramms des World Wildlife Funds (WWF) zu verdreifachen. Die ursprüngliche, branchenweit führende Verpflichtung des Unternehmens zu einer achtprozentigen Reduzierung bis 2013, die es 2008 bei seinem Eintritt in das Klimaschutzprogramm eingegangen war, wurde auf 25 % erhöht und soll in d

Preparis: Businesses Must Share Blame for Spread of H1N1

Fri, 6 Nov 2009 12:03:00 UT

ATLANTA--(BUSINESS WIRE)--Preparis, Inc. today associated the rapid spread of H1N1 pandemic to the high percentage of companies that are not doing enough to prevent its spread in the workplace. In response, the company has unveiled a special website dedicated to helping businesses and their employees prepare for the “swine flu” pandemic. This free service, called H1N1 Central, takes a decidedly business-centric and hands-on approach. It can be found at www.preparis.com. “The wo

Covidien achève avec succès son OPA sur les actions d’Aspect Medical Systems, Inc.

Fri, 6 Nov 2009 12:00:00 UT

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE : COV), fournisseur mondial de produits de soins de santé de premier plan, a annoncé aujourd’hui l’achèvement fructueux de l'OPA que la société a lancée par l'intermédiaire de sa filiale Transformer Delaware Corp. en vue d'acquérir l’ensemble des actions ordinaires en circulation d’Aspect Medical Systems, Inc. L’OPA est arrivée à expiration à minuit (Heure de l’Est)

Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations

Fri, 6 Nov 2009 12:00:00 UT

BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (NASDAQ: NRGN), a drug development company historically focused on drugs for psychiatric and neurological disorders, today announced financial and operating results for the quarter ended September 30, 2009. The Company also announced its analysis of results from a previously suspended Phase 2 study of aplindore in Restless Legs Syndrome (RLS) and that it has entered into an agreement to sell all real estate owned by the Company. Stephen R. D

King Pharmaceuticals to Present at Credit Suisse Healthcare Conference

Fri, 6 Nov 2009 12:00:00 UT

BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a live webcast of its presentation scheduled for Thursday, November 12, 2009, at 9:00 am Mountain Standard Time (11:00 am Eastern Standard Time), at the Credit Suisse 2009 Healthcare Conference at the Arizona Biltmore Hotel in Phoenix, Arizona. The presentation may include a discussion of the Company’s marketed products, pipeline, strategy for growth, financial results and expectations, a

Research and Markets: Advising Clients on New Medicare Reporting Requirements with the Center for Medicare and Medicaid Services

Fri, 6 Nov 2009 12:00:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/e4d973/advising_clients_o) has announced the addition of the "Advising Clients on New Medicare Reporting Requirements with the Center for Medicare and Medicaid Services" audioconference to their offering. "Advising Clients on New Medicare Reporting Requirements with the Center for Medicare and Medicaid Services" is a time efficient way for health care lawyers to be in-the-know on the most up to date facts a

Spectrum Pharmaceuticals Announces Date for Third Quarter 2009 Corporate Update and Pipeline Review Conference Call

Fri, 6 Nov 2009 12:00:00 UT

IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced the date and time for its third quarter 2009 corporate update and pipeline review conference call. Conference Call Friday, November 13, 2009 @ 1:00 p.m. Eastern/10:00 a.m. Pacific Domestic: 888-339-3507 International: 719-325-2342 Webcast and replays: www.sppirx.com Audio replays will be available through November 23, 2009 Domestic:

Covidien culmina exitosamente una oferta pública de compra de acciones de Aspect Medical Systems, Inc.

Fri, 6 Nov 2009 12:00:00 UT

DUBLÍN--(BUSINESS WIRE)--Covidien (NYSE: COV), líder mundial en suministros de productos sanitarios, anunció hoy la culminación exitosa de una oferta pública a través de su subsidiaria, Transformer Delaware Corp., para la compra de todas las acciones ordinarias en circulación de Aspect Medical Systems, Inc. La oferta pública expiró a las 24 hs, zona horaria europea, del día 5 de noviembre de 2009, no se prolongó el plazo. Los depositarios para la

Riassunto: Covidien porta a termine con successo l'offerta di acquisto delle azioni di Aspect Medical Systems, Inc.

Fri, 6 Nov 2009 12:00:00 UT

DUBLINO--(BUSINESS WIRE)--Covidien (NYSE: COV), un leader mondiale nel settore dei prodotti sanitari, ha annunciato oggi di aver portato a termine con successo, tramite la consociata Transformer Delaware Corp., la sua offerta di acquisto di tutte le azioni ordinarie in circolazione di Aspect Medical Systems, Inc. L'offerta di acquisto è scaduta a mezzanotte (ora della costa orientale degli Stati Uniti) del 5 novembre 2009 e non è stata prolungata. Il depositario dell'offerta di acquist

Greater Washington, DC Marriott Hotels Host Torch Relay to Raise Money for Children’s Miracle Network

Fri, 6 Nov 2009 12:00:00 UT

BETHESDA, Md.--(BUSINESS WIRE)--Representatives from Marriott hotels throughout the Washington, DC, area, along with co-workers, customers friends and family, joined forces last week to participate in a Torch Relay to benefit Children’s Miracle Network. This walk, from Marriott International’s corporate headquarters in Bethesda, to the Marriott Bethesda North Hotel & Conference Center, drew more than 350 participants--more than triple the number from last year. All proceeds went

Covidien bringt Übernahmeangebot für Aktien von Aspect Medical Systems, Inc. erfolgreich zum Abschluss

Fri, 6 Nov 2009 12:00:00 UT

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), ein weltweit tätiger, führender Anbieter von Gesundheitsprodukten, gab heute bekannt, dass sein Übernahmeangebot für den Kauf aller im Umlauf befindlichen Stammaktien von Aspect Medical Systems, Inc. durch seine Tochtergesellschaft Transformer Delaware Corp. erfolgreich zum Abschluss gebracht wurde. Die Angebotsfrist endete am 5. November 2009, 24 Uhr ET, und wurde nicht verlängert. Nach Mitteilung der für das Angebot z

LifePoint Hospitals Reports Third Quarter 2009 Results

Fri, 6 Nov 2009 12:00:00 UT

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Hospitals, Inc. (NASDAQ: LPNT) today announced results for the third quarter and nine months ended September 30, 2009. For the third quarter ended September 30, 2009, revenues from continuing operations were $745.0 million, up 10.4% from $675.1 million for the same period a year ago. Income from continuing operations attributable to LifePoint Hospitals, Inc. for the third quarter ended September 30, 2009, increased 12.4% to $32.1 million, or $0.5

Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc.

Fri, 6 Nov 2009 12:00:00 UT

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009, and was not extended. The depositary for the tender offer has advised Covidien that, as of the expiration of the offerin

Inhibitex Reports Third Quarter 2009 Financial Results

Fri, 6 Nov 2009 12:00:00 UT

ATLANTA--(BUSINESS WIRE)--Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the third quarter ended September 30, 2009. The Company held cash, cash equivalents and short-term investments of $21.1 million at September 30, 2009, as compared to $33.1 million at December 31, 2008. “We continue to make progress on all fronts, including the advancement of our differentiated antiviral development programs and most recently, the completion of a financing that we believe str

Research and Markets: UK Healthcare Sector Report: an Essential Tool to Help Your Company Gain an in-Depth Knowledge and Competitive Advantage in the Industry

Fri, 6 Nov 2009 11:28:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2a9dc8/uk_healthcare_sect) has announced the addition of the "UK Healthcare Sector: Sector Report" report to their offering. This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics and economic indicators. It analyzes the critical success factors in the in

Research and Markets: US Healthcare Sector Report: an Essential Tool to Help Your Company Gain an in-Depth Knowledge and Competitive Advantage in the Industry

Fri, 6 Nov 2009 11:23:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f6a771/us_healthcare_sect) has announced the addition of the "US Healthcare Sector: Sector Report" report to their offering. This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics and economic indicators. It analyzes the critical success factors in the in

Research and Markets: This Essential Q4 2009 South Africa Pharmaceuticals and Healthcare Report Provides Independent Forecasts and Competitive Intelligence on the Industry

Fri, 6 Nov 2009 11:19:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/14adad/south_africa_pharm) has announced the addition of the "South Africa Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. South Africa Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on South Afr

Research and Markets: Johnson & Johnson: The Essential Corporate Analysis

Fri, 6 Nov 2009 11:18:00 UT

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d67d72/johnson_johnson) has announced the addition of the "Johnson & Johnson: Corporate Analysis" company profile to their offering. This company profile is a premium company information product offering an unmatched depth and breadth of content. It analyzes the strategic positioning of the company - how the company has evolved and how it has been performing over the years. Sectional Highlights: Structu